Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study

OBJECTIVE: Our study aimed to evaluate the main factors affecting the efficacy of anlotinib to determine the therapeutically dominant populations. METHODS: The medical records of patients with lung cancer who were treated with anlotinib from July 2018 to February 2020 at Renji Hospital, School of Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Bijun, Tan, Xiaoming, Lou, Yueyan, Zheng, Yu, Zhang, Liyan, Wu, Xueling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591656/
https://www.ncbi.nlm.nih.gov/pubmed/34758674
http://dx.doi.org/10.1177/03000605211046173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591656/
https://www.ncbi.nlm.nih.gov/pubmed/34758674
http://dx.doi.org/10.1177/03000605211046173

Ejemplares similares